4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-108151
Chief Scientific Officer sold 2,339 shares at $34.55 ($80,812)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-09-18 | Sale 10b5-1 | −2,339 | $34.55 | $80,812 | 140,375 | D |
| Open-market sales · 2,339 sh · avg $34.55 · $80,812 | |||||||
Loading xslF345X05/ownership.xml…